Skip to main content

Drug Safety

Podcast microphone headphones
Day 1 (part one): ACR 2019 Podcast
RheumNow
Podcast microphone headphones
Day 1 (part two): ACR 2019 Podcast
RheumNow
Podcast microphone headphones
Podcast microphone headphones
Day 4: ACR 2019 Podcast
RheumNow
Podcast microphone headphones
Day 3: ACR 2019 Podcast
RheumNow
RheumNow Podcast – ACR 2019  Round Up (11.15.19)
Dr. Jack Cush presents his favorite abstracts and presentations from Rheumatology Round Up and ACR 2019.
  • #1223 ALLN-346 a urate degrading enzyme in a pig model of gout
  • #L06 Emapalumab for treating MAS in systemic JIA patients
  • #1890 and 2357 Methotrexate Safety from CIRT
  • #1240 Anakinra in acute gout – anaGO study
  • #2292, #2279 When to withdraw biologics in RA patients who become pregnant
  • #633, #631 Delays in referral of LBP
  • #196 VTE risk and future ASCVD risk
  • #2566 Polypharmacy
  • #860 EMBRACE – Belimumab in Blacks
Podcast microphone headphones
ACR Posters
ACR 2019 - Report from Day 3 (Tuesday)
Jack Cush, MD
Here's my summary of key studies presented Tuesday.  Tofacitinib in Polyarticular JIA Abstract L22. Dr. Hermine Brunner presented the results of a phase 3 trial of tofacitinib (Tofa) in children…
iv infusion hospital drip
Rheumatic immune-related adverse events can start at almost any time after the commencement after immune checkpoint inhibitor immunotherapy for cancer, and are liable to persist long after the…
Panel Presentation: Psoriatic Arthritis

Drs. Eric Ruderman, Alexis Ogdie, Jessica Walsh, and Jose Scher discuss the giselkumab trials, where IL-23 inhibitors fit in practice, ixekizumab withdrawal, and more that presented at the 2019 ACR/ARP annual meeting in Atlanta. 

vaccine shot
Herpes Zoster Vaccine Update
Cassandra Calabrese, DO
Shingrix (GSK), the herpes zoster subunit vaccine (a two-shot series), was approved by the FDA in Fall 2018 and is currently approved for use in adults 50 years and older. Shingrix has replaced the…
Panel Presentation: Spondyloarthritis

Drs. Jack Cush, Christopher Ritchlin, Sophia Ramiro, Lianne Gensler, and Jessica Walsh discuss interesting new trials and data presented in ankylosing spondylitis and spondyloarthritis at the 2019 ACR/ARP annual meeting in Atlanta.  

Panel Presentation: Gout

Drs. Jack Cush, Nicola Dalbreth, Ken Saag and Robert Keenan discuss several gout presentations, including tart cherry, safety and efficacy of therapies, quality of life issues and more at the 2019 ACR/ARP annual meeting in Atlanta. 

Lupus Pearls: Dr. Kathryn Dao

Dr. Dao reviews several lupus pearls delivered by Dr. Michelle Petri at the 2019 ACR/ARP annual meeting in Atlanta. 

Tofacitinib as Monotherapy Following MTX Withdrawal in PsA: Dr. Eric Ruderman

Dr. Ruderman describes abstract #L14 presented at the 2019 ACR/ARP annual meeting in Atlanta. 

SJIA-associated ILD: Dr. Jonathan Hausmann

Dr. Hausmann describes a new inflammatory lung disease at the 2019 ACR/ARP annual meeting in Atlanta. 

Rheumatology Pearls from Dr. Sterling West: Dr. Kathryn Dao

Dr. Dao shares pearls presented by Dr. West at the 2019 ACR/ARP annual meeting in Atlanta. 

Romosozumab and Patients with Chronic Kidney Disease: Dr. Arthur Lau

Dr. Lau discusses abstract #2730 presented at the 2019 ACR/ARP annual meeting in Atlanta. 

New Treatments for Axial Spondyloarthritis: Dr. Antoni Chan

Dr. Chan discusses several studies on spondyloarthritis presented at the 2019 ACR/ARP annual meeting in Atlanta. 

Ixekizimab Withdrawal in PSA: Dr. Eric Ruderman

Dr. Ruderman highlights abstract #1532 at the 2019 ACR/ARP annual meeting in Atlanta.

×